Results 161 to 170 of about 1,086,070 (250)

Drug-resistance profiles, population structure, genomic clustering, and temporal trends in drug resistance among <i>Mycobacterium tuberculosis</i> complex isolates in Ukraine, 2019-2023: a multicentre cohort study. [PDF]

Lancet Reg Health Eur
Butov D, Butova T, Miasoiedov V, Feshchenko Y, Nakonechna O, Kuzhko M, Rosenthal A, Grinev A, Hoppes D, Kilmnick J, Levandovska D, Hryhorieva A, Vekshyn V, Abramova L, Niemann S, Dreyer V, Ukrainian TB Portal Collaborators.   +16 more
europepmc   +1 more source

Epidemiology, risk factors and clinical outcomes of multidrug-resistant <i>Pseudomonas aeruginosa</i> colonization in bronchiectasis: a territory-wide study in Hong Kong. [PDF]

J Thorac Dis
Yuan Z, Tsang LK, Ho JCM, Hung IFN, Kwok WC.   +4 more
europepmc   +1 more source

Trends and Characteristics of Drug-Resistant Tuberculosis: A Five-Year Study at a Major Specialized Hospital in Guizhou, China (2018-2023). [PDF]

Infect Drug Resist
Huang J, Cao X, Wang M, Du L, Chen X, Tu Y, Feng Y.   +6 more
europepmc   +1 more source

Spatial clustering and transmission networks of multidrug-resistant tuberculosis in Rwanda: a national retrospective genomic and spatial epidemiological study. [PDF]

BMJ Open
Cuella-Martin I, Hakizayezu F, Mulders W, Niyompano H, Runyambo D, Keysers J, De Rijk WB, Habimana Mucyo Y, Migambi P, Muvunyi CM, Meehan CJ, de Jong BC, Rigouts L, Ngabonziza JCS, Mitchell E.   +14 more
europepmc   +1 more source

Synthesis and evaluation of novel 3,5-dinitrobenzoyl substituted amino acid hydrazides against <i>Mycobacterium tuberculosis</i>. [PDF]

RSC Med Chem
Alsalem FM, Brown AK, Crowhurst AK, Taylor CA, Larkin LG, Gill JH, Sellars JD.   +6 more
europepmc   +1 more source

Determinants of favorable treatment outcomes in multidrug-resistant tuberculosis in Zambia: A retrospective cross sectional study, 2018-2022. [PDF]

PLoS One
Kalaba D, Chanda C, Mputu M, Benson HM, Mutalange M, Siame L, Masenga SK, Chewe W, Sikambale K, Mwewa K, Chirwa U, Sitali DM, Mumba C, Mununga K, Chanda-Kasese N, Liusha N, Mushota K, Mtonga W, Lungu P, Mubanga A, Kazonga E, Kayeyi N.   +21 more
europepmc   +1 more source

Genetic susceptibility to aminoglycoside cochleotoxicity in South African multidrug-resistant and rifampicin-resistant tuberculosis patients. [PDF]

S Afr J Commun Disord
Ghafari N, Ramma L, Court R, Manyisa N, McIlleron H, Petersen L.   +5 more
europepmc   +1 more source

Whole-genome sequencing reveals lineage-associated drug resistance and enables machine learning-based prediction in <i>Mycobacterium tuberculosis</i> clinical isolates. [PDF]

Front Microbiol
Hao Z, Wu C, Peng Y, Zhou L, Li J, Zou X.   +5 more
europepmc   +1 more source

HIV-tuberculosis co-infection in Liangshan, a resource-limited region of Southwest China: trends and implications in the context of integrated prevention, 2019-2024. [PDF]

Infect Dis Poverty
Bai X, Wang J, Yu G, Shi J, Fan S, Wang R, Wang Y, Feng X, Pei R, Liao R.   +9 more
europepmc   +1 more source

Burden of Rifampicin Resistance Among Patients With Tuberculosis at a Tertiary Care Center in Uttarakhand, India: A Prospective Cross-Sectional Study. [PDF]

Cureus
Negi S, Singh M, Chandola I, Rawat J.
europepmc   +1 more source